Market Insights report
Vaccines are covered against infectious diseases. They help to prevent diseases, usually through active immunization. Vaccines against infectious diseases transmitted by viruses (e.g., hepatitis A and B or COVID-19) and bacteria (e.g., typhoid fever or meningococcus) are included. Different types of COVID-19 vaccines (mRNA-based, viral vector vaccines) are considered.
What's included?
The Vaccines market is one of the largest parts of the Pharmaceuticals market. With only a few important players, the Vaccines market is very concentrated. A few new players have entered the market due to COVID-19 vaccines, and these vaccines have led to a major growth boost. They were developed under high time pressure but prove to be highly effective, and billions of doses have been produced. Demand for COVID-19 vaccines is expected to continue throughout the coming years. The mRNA-based COVID-19 vaccines are the first approved drugs of their kind, boosting this research area. The growth of revenues generated by other types of vaccines has declined since the start of the pandemic.
Overview
Market numbers
We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)